EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis

Katrin Pape iD, Nicholas Hanuscheck, Samantha Schmaul, Flores Kneilmann, Georg Bündgen, Beatrice Wasser, Falk Steffen iD, Sinah Engel, Felix Luessi iD, Matthias Klein, Toszka Bohn, Tobias Bopp und 2 weitere

Brain · 2026

DOI: 10.1093/brain/awaf268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2026. Verfasst von Katrin Pape und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), University Medical Center of the…. Hauptthemen laut MEDLINE: Th17 Cells, Multiple Sclerosis, Signal Transduction, CD5 Antigens. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft DFG, Hermann and Lilly Schilling Foundation, Centre for Healthy Ageing (CHA) Mainz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pro-inflammatory T-helper 17 (Th17) cells are of vital importance in human autoimmune diseases such as multiple sclerosis (MS). Due to differentiation and functional plasticity, Th17 cells are able to produce a variety of pro-inflammatory cytokines such as interleukin (IL)-17A, interferon (IFN)-γ and granulocyte-macrophage colony-stimulating factor (GM-CSF), and modulation of Th17 cell activities represents a desirable tool for disease-modifying treatment. Here, we aimed to understand the role of the surface molecule CD5 and its intracellular interaction partner casein kinase 2 (CK2) in human Th17 effector function as well as their role in multiple sclerosis. We performed targeted single-cell RNA sequencing from CSF obtained from people with multiple sclerosis and non-inflammatory neurological diseases, and high-sensitivity proteomic analysis of serum and CSF from 114 people with multiple sclerosis by using a proximity extension assay (PEA) together with functional investigations on CD4+ memory T cells differentiated into a Th17-polarized phenotype. Blockade of CD5 reduced the production of IL-17A, IFN-γ and GM-CSF by Th17-polarized cells without affecting proliferation. In comparison, blockade of its intracellular interaction partner CK2 exerted partly similar effects with a decrease in IL-17A and GM-CSF production but also impaired T cell proliferation. Both blocking agents resulted in a decreased phosphorylation of the downstream signalling molecule STAT3. The CD5 targeting treatment was able to abolish cytotoxic effects caused by Th17-polarized cells. Importantly, transcriptomic and proteomic analysis showed that CD5 expression correlates with an inflammatory immune profile in multiple sclerosis in serum as well as CSF. Our study highlights the importance of the CD5-CK2-STAT3 signalling axis for inflammatory responses of human Th17-polarized cells. Since in humans CD5 expression correlates with inflammation and cellular injury, targeting the CD5 signalling pathway provides future therapeutic opportunities for—among other diseases—multiple sclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Th17 CellsMultiple SclerosisSignal TransductionCD5 AntigensHumansFemaleMaleAdultMiddle AgedCasein Kinase IICytokinesCell DifferentiationInterleukin-17

Stichwörter der Autor:innen

CD5CK2Th17 cellsimmunomodulationmultiple sclerosis

Substanzen

CD5 AntigensCasein Kinase IICytokinesInterleukin-17

Autor:innen und Institutionen

  • Department of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz 55131, Germany.
  • Institute for Immunology, Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz 55131, Germany.
  • German Cancer Consortium (DKTK), Heidelberg D-69120, Germany.

ORCID-Profile: Katrin Pape, Falk Steffen, Felix Luessi, Stefan Bittner, Frauke Zipp

Förderung

  • Deutsche Forschungsgemeinschaft DFG
  • Hermann and Lilly Schilling Foundation
  • Centre for Healthy Ageing (CHA) Mainz

Zitieren

APA

Pape, K., Hanuscheck, N., Schmaul, S., Kneilmann, F., Bündgen, G., Wasser, B., Steffen, F., Engel, S., Luessi, F., Klein, M., Bohn, T., Bopp, T., Bittner, S., & Zipp, F. (2026). Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis. Brain. https://doi.org/10.1093/brain/awaf268

Vancouver

Pape K, Hanuscheck N, Schmaul S, Kneilmann F, Bündgen G, Wasser B, et al. Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis. Brain. 2026. doi:10.1093/brain/awaf268

BibTeX
@article{Pape2026,
  author = {Pape, Katrin and Hanuscheck, Nicholas and Schmaul, Samantha and Kneilmann, Flores and Bündgen, Georg and Wasser, Beatrice and Steffen, Falk and Engel, Sinah and Luessi, Felix and Klein, Matthias and Bohn, Toszka and Bopp, Tobias and Bittner, Stefan and Zipp, Frauke},
  title = {Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis},
  journal = {Brain},
  year = {2026},
  doi = {10.1093/brain/awaf268}
}
Kostenlos starten →